Rst model
Rst model has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Nov 2, 2026: “Comparative Diagnostic Specificity of Two Independent Artificial Intelligence Electrocardiogram Algorithms for Pre-Participation Cardiovascular Screening in Athletes”.
1 paper studies it1 findingUpdated
1 new paper in 30 daysSee all 1 papers on rst model
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“two independently developed AI-ECG algorithms demonstrated significantly different diagnostic specificity for HCM and AMY”
- 1 lab in 1 country
- Humans1
What did studies of rst model find?
1Studies of rst model measured one outcome, Diagnostic specificity for hypertrophic cardiomyopathy or cardiac amyloidosis.
Diagnostic specificity for hypertrophic cardiomyopathy or cardiac amyloidosis
upin humans1
1 study
Diagnostic specificity for hypertrophic cardiomyopathy or cardiac amyloidosis
upin humans1
Rst model is linked with higher diagnostic specificity for hypertrophic cardiomyopathy or cardiac amyloidosis in humans (Healthy athletes without structural heart disease; RST model compared with AZ model) (Specificity 98.0% (95% CI 96.7–98.9) versus 93.5% (95% CI 91.5–95.2); p<0.001).
“two independently developed AI-ECG algorithms demonstrated significantly different diagnostic specificity for HCM and AMY”
HumansHealthy athletes without structural heart disease; RST model compared with AZ model86.5% malesn = 738
AHA Scientific Sessions 2026 abstract